| Title |
Author |
Type |
Date |
Words |
| Oncolytics Biotech[R] Inc. Signs Sponsorship Pact with NCIC CTG. |
|
Clinical report |
May 31, 2012 |
379 |
| Common painkillers tied to lower skin cancer risk: study. |
|
|
May 30, 2012 |
523 |
| City man in cancer drug first. |
|
|
May 30, 2012 |
354 |
| Russia's Colorectal Cancer Drug Market Projected to Grow to More Than $480 Million in 2016. |
|
|
May 30, 2012 |
585 |
| Tikcro Technologies Reports 2012 First Quarter Results. |
|
|
May 30, 2012 |
2880 |
| SCRI Investigators are Authors on 60 Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. |
|
Conference news |
May 30, 2012 |
813 |
| Foundation Medicine Launches FoundationOne[TM]. |
|
Clinical report |
May 30, 2012 |
1039 |
| Exelixis Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer. |
|
|
May 30, 2012 |
851 |
| Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer. |
|
|
May 30, 2012 |
1478 |
| First Patient Completes Treatment Successfully at ProCure Proton Therapy Center in N.J. |
|
|
May 30, 2012 |
720 |
| Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO. |
|
|
May 29, 2012 |
1555 |
| EQUICARE CS Cancer Survivorship Case Management Software Listed as a "Best Practices" Resource by the American College of Surgeons Commission on Cancer (COC). |
|
|
May 29, 2012 |
758 |
| MINORITIES MISS OUT ON CANCER TREATMENT; Language barrier affects communication. |
|
|
May 29, 2012 |
439 |
| Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers. |
|
|
May 29, 2012 |
407 |
| Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO). |
|
|
May 29, 2012 |
1377 |
| Verastem to Present Scientific Data at the 2012 ASCO Annual Meeting. |
|
|
May 29, 2012 |
660 |
| CytRx Announces the Publication of INNO-206 Findings in Multiple Myeloma in Clinical Cancer Research. |
|
|
May 29, 2012 |
1020 |
| Research and Markets: Pharmacogenomics in Clinical Therapeutics: Comprehensive Overview for All Clinicians, Pharmacologists and Clinical Laboratory Professionals. |
|
|
May 29, 2012 |
355 |
| Advaxis Completes Enrollment in Phase 2 Cervical Cancer Study. |
|
Report |
May 29, 2012 |
791 |
| National Cancer Survivors Day and Multiple Cancer Studies Focus on Survivor Quality of Life, As Breast Cancer 5 Year Survival Rate Reaches 90% in U.S. |
|
|
May 29, 2012 |
1324 |
| Bio-Path Holdings Successfully Completes Third Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia. |
|
|
May 29, 2012 |
2037 |
| /C O R R E C T I O N -- Novocure/. |
|
|
May 29, 2012 |
1305 |
| Novocure(TM) to Present NovoTTF(TM) Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology. |
|
Clinical report |
May 29, 2012 |
1220 |
| Trials offer the best hope for treating cancer at home and abroad; More than 200 years after the first clinical trials were carried out, Gareth Griffiths examines the work of the Welsh Cancer Trial Unit and shows how its work now has international significance. |
|
|
May 28, 2012 |
918 |
| Patients need support to overcome cancer poverty; After the shocking revelations about the financial cost of cancer to patients, Elin Jones says better access to financial advice is needed. |
|
|
May 28, 2012 |
621 |
| Women get less information on post-cancer infertility. |
|
|
May 28, 2012 |
381 |
| Anti-psychotic drug kills cancer stem cells without side-effects: study. |
|
|
May 27, 2012 |
392 |
| Anti-Psychotic Drugs Found to Bust Cancer Cells. |
|
|
May 26, 2012 |
309 |
| Minister rules out cancer drug fund. |
|
|
May 25, 2012 |
174 |
| Minister under fire over cancer drugs fund stance; GRIFFITHS SAYS THAT MOVE WOULD NOT BE IN PATIENTS' BEST INTERESTS. |
|
|
May 25, 2012 |
650 |
| Drug may 'tame' cancer cells. |
|
|
May 25, 2012 |
252 |
| Cancer drugs fund stance offers little comfort to those affected; Western Mail. |
|
|
May 25, 2012 |
450 |
| Minister says no to cancer drugs fund. |
|
|
May 25, 2012 |
372 |
| New drug destroys human cancer stem cells without affecting healthy ones. |
|
|
May 25, 2012 |
281 |
| Pfizer's Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU. |
|
|
May 25, 2012 |
1928 |
| Research and Markets: Four-S Fortnightly PharmaHealth Track - Newsletter on Indian Healthcare Industry - Issue 5 - Cipla Makes Significant Price Cuts on 3 Cancer Drugs. |
|
|
May 25, 2012 |
374 |
| Elekta: The US Oncology Network to Standardize on Elekta's MOSAIQ Oncology Information System. |
|
|
May 24, 2012 |
671 |
| Novocure(TM) Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy. |
|
|
May 24, 2012 |
1140 |
| Spin-out promises a 'year of delivery'. |
|
|
May 23, 2012 |
475 |
| MDxHealth's ConfirmMDx[TM] for Prostate Cancer Test Helps to Identify Men Able to Avoid Repeat Biopsies. |
|
|
May 23, 2012 |
1259 |
| AVEO Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors. |
|
|
May 23, 2012 |
1118 |
| New breast cancer test to precisely predict if tumour will return post surgery. |
|
|
May 23, 2012 |
528 |
| Breast MRI 'better than clinical approach for predicting chemotherapy's efficiency'. |
|
|
May 23, 2012 |
441 |
| Senesco's SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma. |
|
Clinical report |
May 23, 2012 |
821 |
| Seattle Genetics Announces Health Canada Accepts ADCETRIS[R] New Drug Submission for Review. |
|
|
May 23, 2012 |
824 |
| MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage. |
|
|
May 23, 2012 |
678 |
| Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease. |
|
|
May 23, 2012 |
2883 |
| Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer. |
|
|
May 23, 2012 |
1130 |
| New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer. |
|
|
May 23, 2012 |
1263 |
| Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy. |
|
|
May 22, 2012 |
941 |
| 'Orphan' sleep drug could be new weapon to fight cancer. |
|
|
May 22, 2012 |
491 |
| IsoRay's GliaSite Approved for Sale in 31 European Countries. |
|
|
May 22, 2012 |
1175 |
| Pharmacokinetics Parameters of Sunshine Biopharma's Lead Anti-Cancer Compound Exceed Expectations. |
|
|
May 22, 2012 |
451 |
| BiovaxID[R] Personalized Lymphoma Vaccine is Featured in Article Published in Scrip Intelligence. |
|
|
May 22, 2012 |
888 |
| Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others. |
|
|
May 22, 2012 |
6724 |
| Mirna Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate. |
|
|
May 22, 2012 |
707 |
| e-Therapeutics' Preliminary Results for the Year Ended 31 January 2012. |
|
|
May 22, 2012 |
22518 |
| Diamyd Medical's Phase II study in cancer pain fully recruited. |
|
|
May 22, 2012 |
1039 |
| 600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study. |
|
Clinical report |
May 21, 2012 |
1490 |
| New type of prostate cancer discovered. |
|
|
May 21, 2012 |
974 |
| Three Abstracts on the ChemoFx[R] Drug Response Marker Accepted by ASCO. |
|
|
May 21, 2012 |
441 |
| VBL Therapeutics Presents Positive Preclinical Data for VB-201 in Inflammatory Bowel Disease at Digestive Disease Week (DDW) 2012. |
|
|
May 21, 2012 |
760 |
| Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting. |
|
|
May 21, 2012 |
1695 |
| Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR[R] Scan KRAS Kit in Europe. |
|
|
May 21, 2012 |
1286 |
| Genesis Biopharma Issues Letter To Shareholders. |
|
|
May 21, 2012 |
1236 |
| Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans. |
|
|
May 21, 2012 |
1661 |
| AUA Disputes Panel's Recommendations On Prostate Cancer Screening. |
|
|
May 21, 2012 |
679 |
| CANCER BOOST. |
|
|
May 19, 2012 |
190 |
| Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data at the 2012 ASCO Annual Meeting. |
|
Conference news |
May 18, 2012 |
1344 |
| Research and Markets: Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion. |
|
|
May 18, 2012 |
403 |
| ZYTIGA (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. |
|
|
May 18, 2012 |
1597 |
| Biovest Announces BiovaxID[R] ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study. |
|
|
May 18, 2012 |
977 |
| ZYTIGA (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. |
|
|
May 18, 2012 |
2010 |
| Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting. |
|
Clinical report |
May 17, 2012 |
1217 |
| Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer. |
|
|
May 17, 2012 |
1643 |
| Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer. |
|
|
May 17, 2012 |
841 |
| SILENCE THERAPEUTICS PLC - New data from Phase I trial with Atu027. |
|
|
May 17, 2012 |
974 |
| Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN[R] in Combination with the Redox Modulating Agent Motexafin Gadolinium (MGd). |
|
|
May 17, 2012 |
1392 |
| Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer. |
|
|
May 17, 2012 |
961 |
| US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA. |
|
|
May 17, 2012 |
956 |
| Northwest Bio Provides Update On DCVax-L Brain Cancer Trial. |
|
|
May 17, 2012 |
1090 |
| Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting. |
|
|
May 17, 2012 |
393 |
| Positive Phase 2 Clinical Data with Tivantinib in Hepatocellular Carcinoma to Be Highlighted in Oral Presentation at 2012 Annual Meeting of American Society of Clinical Oncology. |
|
Clinical report |
May 17, 2012 |
1492 |
| Tokai Pharmaceuticals' Galeterone Phase 1 Data in Patients with Advanced Prostate Cancer to be Presented at ASCO Annual Meeting 2012. |
|
|
May 17, 2012 |
853 |
| New Research Computing Cluster for Childhood Cancer Ready to Help Fast-Track Targeted Treatments. |
|
|
May 17, 2012 |
1130 |
| Susan G. Komen for the Cure[R] Targeting Full Spectrum of Cancer Treatment with $58 Million in 2012 Research Grants. |
|
|
May 17, 2012 |
1583 |
| Tunisian Diplomat Hails Iran's Scientific Achievements. |
|
|
May 17, 2012 |
512 |
| Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine. |
|
|
May 17, 2012 |
1204 |
| Frost & Sullivan: New Innovations in the Rapidly Growing U.S. Breast Cancer Pharmaceutical Market. |
|
|
May 16, 2012 |
1102 |
| Competence of health board managers called into question; CONFUSION AFTER QUERY OVER FIGURES FOR RADIOTHERAPY. |
|
|
May 16, 2012 |
640 |
| New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia. |
|
|
May 16, 2012 |
886 |
| New Clinical Data Highlighting Foundation Medicine's Comprehensive Cancer Genomic Profile to be Presented at 2012 ASCO Annual Meeting. |
|
|
May 16, 2012 |
2231 |
| Precision Therapeutics Supports The 12th Annual Women's Health & Fitness Expo 2012 in Honor of National Women's Health Week. |
|
|
May 16, 2012 |
433 |
| Dendreon Announces Presentation of PROVENGE Data at the 2012 American Society of Clinical Oncology Annual Meeting. |
|
|
May 16, 2012 |
2136 |
| Children with Cancer Have Complete Responses in a Children's Oncology Group Phase 1 Trial. |
|
|
May 16, 2012 |
1250 |
| Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012. |
|
|
May 16, 2012 |
2308 |
| Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer. |
|
Clinical report |
May 16, 2012 |
2044 |
| Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting. |
|
|
May 16, 2012 |
1952 |
| Analysis of Data from Two Phase 3 Studies Shows DIFICID Offered Faster Diarrheal Symptom Improvement than Oral Vancomycin in Patients with Cancer Being Treated for Clostridium difficile-Associated Diarrhea (CDAD). |
|
|
May 16, 2012 |
1650 |
| Prostate cancer drug gets approval. |
|
|
May 16, 2012 |
279 |
| MDxHealth Provides First Quarter 2012 Business Update. |
|
|
May 16, 2012 |
1482 |
| Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012. |
|
|
May 16, 2012 |
3837 |
| Reminder: Exelixis Announces Data Presentations, Webcast of Investor Briefing in Conjunction With 2012 ASCO Annual Meeting. |
|
|
May 16, 2012 |
1175 |
| Frost & Sullivan: New Innovations in the Rapidly Growing U.S. Breast Cancer Pharmaceutical Market. |
|
|
May 16, 2012 |
1100 |
| Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial. |
|
|
May 16, 2012 |
1719 |
| BSD Medical Corporation Announces Investor Conference Call. |
|
|
May 16, 2012 |
491 |
| NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay. |
|
|
May 16, 2012 |
836 |
| Biovest Retains Ferghana Partners to Evaluate Strategic Transactions. |
|
|
May 16, 2012 |
723 |
| CaroMont Cancer Program Receives Top National Distinction. |
|
|
May 16, 2012 |
852 |
| I wish my tax could go on Katie's cancer treatment - not a new foyer; YouSAY IN YOUR OPINION. |
|
|
May 15, 2012 |
111 |
| BSD Medical Completes Implementation of New MicroThermX[R] Direct Sales Program in Major U.S. Metropolitan Areas. |
|
|
May 15, 2012 |
718 |
| Advaxis Retires $4.5 Million in Debt, Adds $1,240,000 in New Financing. |
|
|
May 15, 2012 |
1102 |
| CEL-SCI's Chief Scientific Officer Presents at Cancer Symposium. |
|
|
May 15, 2012 |
594 |
| Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma. |
|
|
May 15, 2012 |
959 |
| IsoRay, Inc. Reports Third Quarter Results. |
|
|
May 15, 2012 |
4257 |
| Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers. |
|
|
May 15, 2012 |
1244 |
| Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic. |
|
|
May 15, 2012 |
1366 |
| BP drugs don't reduce colorectal cancer risk. |
|
|
May 14, 2012 |
348 |
| HELP YOUR FAVOURITE CHARITY WIN pounds 15,000 pounds 15,000. |
|
|
May 14, 2012 |
1320 |
| Fighting cancer with a song in their hearts. |
|
|
May 14, 2012 |
267 |
| Provectus Pharmaceuticals Forms Independent Board to Meet Corporate Governance Requirements. |
|
|
May 14, 2012 |
912 |
| Biovest to Seek Marketing Approval in the EU for BiovaxID[R] Personalized Lymphoma Cancer Vaccine. |
|
|
May 14, 2012 |
1511 |
| Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting. |
|
|
May 14, 2012 |
3459 |
| Cellerant Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure. |
|
|
May 14, 2012 |
911 |
| Senesco to Present SNS01-T, an eIF5A-based Nanoparticle in a Phase 1b/2a Trial to Treat Multiple Myeloma, is Effective in Models of B-Cell Lymphoma. |
|
|
May 14, 2012 |
656 |
| BioAlliance Pharma SA: Initiation of ReLive, phase III clinical trial with Livatag[R] In primary liver cancer. |
|
|
May 14, 2012 |
958 |
| World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments). |
|
|
May 14, 2012 |
3556 |
| US HIFU Adds Mark Carol, MD, As Chief Development Officer. |
|
|
May 14, 2012 |
1101 |
| Lilly Oncology To Disclose New Pipeline Data At ASCO 2012. |
|
|
May 14, 2012 |
1040 |
| Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis. |
|
|
May 14, 2012 |
4666 |
| Novocure Announces Launch of Recurrent Glioblastoma Product Website. |
|
|
May 14, 2012 |
814 |
| Bahrain : BAHRAIN to establish 110 bed cancer facility. |
|
|
May 12, 2012 |
286 |
| Cipla to cut prices of six anti- cancer medicines. |
|
|
May 11, 2012 |
323 |
| Postcode lottery warning after cancer drug refusal. |
|
|
May 11, 2012 |
192 |
| Anger at drug decision. |
|
|
May 11, 2012 |
164 |
| Research and Markets: Global Malignant Melanoma Drug Pipeline Capsule - 2012. |
|
|
May 11, 2012 |
403 |
| Research and Markets: Global Brain Cancer Drug Pipeline Capsule - 2012. |
|
|
May 11, 2012 |
402 |
| Research and Markets: Global Gastric Cancer Drug Pipeline Capsule - 2012. |
|
|
May 11, 2012 |
404 |
| Cancer Experts Detail Treatments using TrueBeam System to Reduce Number of Treatment Sessions and Take Better Account of Motion. |
|
|
May 11, 2012 |
814 |
| Cancer centre a regional first. |
|
|
May 10, 2012 |
418 |
| Bahrain set to open major cancer facility. |
|
|
May 10, 2012 |
424 |
| NCKU Student Wins Prestigious Award for Anti-Cancer Research. |
|
|
May 10, 2012 |
367 |
| Research and Markets: Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019. |
|
|
May 10, 2012 |
618 |
| Molecule that inhibits estrogen, key risk factor for endometrial and breast cancer found. |
|
|
May 10, 2012 |
332 |
| For the Treatment of Advanced Melanoma, Oncologists Report that Yervoy and Zelboraf have Joined Temodar as the Leading Agents for First-line Therapy. |
|
Clinical report |
May 10, 2012 |
794 |
| Urologist "Scrubs" to Face Controversy over Book on Treatment for Prostate Cancer. |
|
|
May 10, 2012 |
744 |
| Elekta pioneers modern cancer care through R&D leadership. |
|
Company overview |
May 10, 2012 |
712 |
| iCAD Announces First European Patients Treated with Xoft Radiation Therapy System. |
|
|
May 10, 2012 |
1344 |
| CEL-SCI Corporation Reports Second Quarter 2012 Financial Results. |
|
|
May 10, 2012 |
5034 |
| Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion. |
|
|
May 10, 2012 |
4979 |
| Commercializing Pancreatic Cancer Drugs: The Faster Route to Consider Your Options and Position of Others. |
|
|
May 10, 2012 |
5081 |
| Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas. |
|
|
May 10, 2012 |
1682 |
| Disappointment for Men With Advanced Prostate Cancer As Life-Extending Drug[1]Refused by NICE. |
|
|
May 10, 2012 |
816 |
| Leading U.K. Cancer Centre Begins Clinical Treatments with New, Revolutionary Beam-shaping Solution from Elekta. |
|
|
May 10, 2012 |
592 |
| Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules. |
|
|
May 10, 2012 |
3163 |
| Leading U.K. Cancer Centre Begins Clinical Treatments with New, Revolutionary Beam-shaping Solution from Elekta. |
|
|
May 10, 2012 |
594 |
| Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas. |
|
|
May 10, 2012 |
1760 |
| RedCannon Security, Inc. and Ovarian Cancer Research Fund (OCRF) launch "Support Ovarian Cancer Research, Prevent Application Downtime" 90-day fundraiser campaign !! |
|
|
May 9, 2012 |
900 |
| Founder of National Children's Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe. |
|
|
May 9, 2012 |
815 |
| Provectus Pharmaceuticals' PV-10 Phase 2 Final Data To Be Presented At 2nd European PostASCO Melanoma Meeting 2012 on June 22, 2012. |
|
Conference news |
May 9, 2012 |
640 |
| Exercise linked to reduced mortality in breast and colon cancer patients. |
|
|
May 9, 2012 |
422 |
| ImmunoCellular Provides an Update on Enrollment for the Company's Phase II Clinical Trial. |
|
|
May 9, 2012 |
687 |
| NCCN Foundation Announces 2012 Young Investigator Awards. |
|
|
May 9, 2012 |
1035 |
| IBN's Droplet Array Sheds Light on Drug-Resistant Cancer Stem Cells. |
|
|
May 9, 2012 |
1002 |
| New Research Shows Minimally Invasive, Video-Assisted Thoracoscopic Lobectomies For Lung Cancer More Cost Effective And Clinically Beneficial Than Traditional, Open Surgery. |
|
|
May 9, 2012 |
1436 |
| Miranda Cosgrove Serves As National Ambassador for The Leukemia & Lymphoma Society's 2012 Light The Night Walks. |
|
|
May 9, 2012 |
738 |
| Cancer drug could treat eye condition. |
|
|
May 8, 2012 |
226 |
| Team's strip deal to boost cancer trust; Club offers up sponsorship to teen charity. |
|
|
May 8, 2012 |
648 |
| Research and Markets: Rising number of cancer cases making India potential market for anti-cancer drugs, finds Netscribes. |
|
|
May 8, 2012 |
404 |
| Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ADXS-HPV for the Treatment of Head and Neck Cancer. |
|
|
May 8, 2012 |
998 |
| GTx Announces Removal of Full Clinical Hold By FDA for Capesaris[R] In Advanced Prostate Cancer. |
|
|
May 8, 2012 |
773 |
| Rafsanjani Blasts West for Denying Iran Vital Drugs. |
|
|
May 8, 2012 |
523 |
| Chavez to return soon to Venezuela after more cancer treatment. |
|
|
May 8, 2012 |
221 |
| Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor. |
|
|
May 8, 2012 |
758 |
| In 2020, FOLFIRI Plus Ramucirumab Will Earn Decision Resources' Proprietary Clinical Gold-Standard Status for the Second-Line Treatment of Metastatic Colorectal Cancer. |
|
|
May 8, 2012 |
770 |
| McKesson Breaks New Ground with InterQual 2012. |
|
|
May 8, 2012 |
814 |
| Intergraph Garden of Hope Gives Tribute to Inspirational Cancer Survivors with Display of Unique Garden Plots. |
|
|
May 8, 2012 |
2110 |
| Penn Receives $25 Million Gift to Create Basser Research Center for Inherited Cancers. |
|
|
May 8, 2012 |
1074 |
| Ruga Corporation Expands Management Team to Advance Its Adapative Response Therapeutics for Cancer Patients. |
|
|
May 7, 2012 |
902 |
| Elekta to Showcase Comprehensive, Integrated Solution Portfolio to Equip Radiation Oncology Departments at ESTRO 2012. |
|
|
May 7, 2012 |
996 |
| Curry ingredient curcumin 'could be key to beating bowel cancer'. |
|
|
May 7, 2012 |
304 |
| How a spice in your vindaloo could be used to fight cancer. |
|
|
May 7, 2012 |
675 |
| Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis. |
|
|
May 7, 2012 |
1359 |
| Action needed on drug funding; Yousay IN YOUR OPINION... |
|
|
May 7, 2012 |
430 |
| New jab offers cancer cure hope. |
|
|
May 7, 2012 |
327 |
| Cancer hope discovered in curry spice. |
|
|
May 7, 2012 |
136 |
| Turmeric cancer fight trial. |
|
|
May 7, 2012 |
188 |
| BSD Medical Reports Hyperthermia Clinical Study on Pancreatic Cancer Highlighted at Society of Thermal Medicine Conference. |
|
Clinical report |
May 7, 2012 |
703 |
| IsoRay to Introduce GliaSite and Cesium-131 Mesh to International Audience at World Congress of Brachytherapy. |
|
|
May 7, 2012 |
1154 |
| Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS[TM] in Patients with CD30-Expressing Relapsed Cutaneous T-cell Lymphoma. |
|
|
May 7, 2012 |
1836 |
| Biovest to Present at Cancer Immunotherapy Leaders Forum. |
|
|
May 7, 2012 |
578 |
| VIP TREAT FOR BOY WHO IS FIGHTING CANCER. |
|
|
May 5, 2012 |
456 |
| Why brain cancer resists chemo. |
Saey, Tina Hesman |
Brief article |
May 5, 2012 |
117 |
| Another side to statins: heart-healthy drugs show promise against inflammation, cancer and the flu. |
Seppa, Nathan |
|
May 5, 2012 |
3048 |
| Indian drug giant Cipla slashes cancer drug prices. |
|
|
May 4, 2012 |
539 |
| Welsh men more likely to get prostate cancer UK PROSTATE CANCER CASES; RISE IN DIAGNOSES LINKED TO INCREASE IN NUMBER OF TESTS. |
|
|
May 4, 2012 |
702 |
| Action needed on cancer drug funding; & COMMENT DEBATE YOUR LETTERS TO THE NATIONAL NEWSPAPER OF WALES. |
|
|
May 4, 2012 |
414 |
| Consultant in thyroid cancer breakthrough. |
|
|
May 4, 2012 |
204 |
| Generon (Shanghai) Corporation Ltd. Initiates a Phase II Clinical Trial for F-627 after US FDA Clearance. |
|
|
May 4, 2012 |
381 |
| Low oxygen levels 'may drive tumour growth in cancer'. |
|
|
May 4, 2012 |
600 |
| Radiofrequency Ablation Prevents Local Cancer Recurrence as Effectively as Radiation Therapy, According to Research Presented at the American Society of Breast Surgeons Annual Meeting. |
|
|
May 4, 2012 |
403 |
| Serono Symposia International Foundation (SSIF) 13th International Workshop on Molecular Targeted Therapy of Cancer (MTTC). |
|
|
May 4, 2012 |
540 |
| Exelixis Expands the Cabozantinib Development Program Through NCI-CTEP Collaboration. |
|
|
May 3, 2012 |
1492 |
| Potential to Revive Abandoned Cancer Drug by Nanoparticle Drug Delivery. |
|
|
May 3, 2012 |
338 |
| Pink Lotus Breast Center to Launch IORT Program Featuring iCAD's Xoft Radiation Therapy System for Breast Cancer Patients. |
|
|
May 3, 2012 |
1021 |
| Dana-Farber's Belfer Institute for Applied Cancer Science to Present at AACR Special Conference Molecular Targeted Therapies: Mechanisms of Resistance. |
|
Conference news |
May 3, 2012 |
285 |
| Biovest Announces that New Clinical Data for BiovaxID[R] Personalized Cancer Vaccine will be Presented by National Cancer Institute at ASCO. |
|
|
May 3, 2012 |
793 |
| New Study Determines that Radiation Therapy Offers Hope and Excellent Restoration In Treating Nonmelanoma Skin Cancer of Eye Lids. |
|
|
May 3, 2012 |
533 |
| ProCure Proton Therapy Center launches interactive online video channel. |
|
|
May 2, 2012 |
858 |
| Mirna Therapeutics Publishes Preclinical Data Demonstrating Therapeutic Effects of microRNA in Hematological Cancer. |
|
|
May 2, 2012 |
650 |
| Advaxis Announces Abstracts Accepted for Poster Presentation at ASCO Annual Meeting 2012. |
|
|
May 2, 2012 |
770 |
| AVEO Announces Preliminary Results of Exploratory Phase 2 Study Evaluating HGF Inhibitor in First-Line Patients with Advanced Lung Cancer. |
|
|
May 2, 2012 |
2096 |
| Teenager is giving back to RVI unit; Family's gratitude to cancer ward. |
|
|
May 2, 2012 |
414 |
| The International Myeloma Foundation Applauds Delaware and Virginia Legislatures for Passing Oral Drug Parity Bills. |
|
|
May 2, 2012 |
682 |
| CLEO: 2012 Press Luncheon Spotlights New Developments in Biophotonics for Cancer Detection, Diagnosis and Treatment. |
|
|
May 2, 2012 |
763 |
| Chavez returns to Cuba for cancer treatment. |
|
|
May 1, 2012 |
651 |
| 'Brake gene' switched off in pancreatic cancer. |
|
|
May 1, 2012 |
358 |
| Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models. |
|
|
May 1, 2012 |
1240 |
| Combination of Lenalidomide and SNS01-T Effective in Cancer Model. |
|
|
May 1, 2012 |
1116 |
| Advaxis Research Accepted for American Association of Immunologists Annual Meeting, Demonstrates Reduction of Tumor Defenses. |
|
|
May 1, 2012 |
787 |
| Gilead Initiates Phase 3 Clinical Trial Evaluating GS-1101 for the Treatment of Chronic Lymphocytic Leukemia. |
|
|
May 1, 2012 |
902 |
| ZIOPHARM Oncology Presents Preclinical Data at AACR Meeting. |
|
|
May 1, 2012 |
880 |
| Immunomedics Radioimmunotherapy of Colorectal Cancer. |
|
Clinical report |
May 1, 2012 |
646 |
| ZIOPHARM Oncology Provides Update on PICASSO 3 Trial. |
|
|
May 1, 2012 |
753 |
| Unions for transfusions: every donation of blood helps to save the lives of up to three people, according to the Australian Red Cross. |
|
|
May 1, 2012 |
432 |
| National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law. |
|
|
May 1, 2012 |
488 |
| For the 200,000 women who receive breast cancer diagnoses each year, the most common form of treatment is a lumpectomy. |
|
|
May 1, 2012 |
175 |
| Estrogen-only HT increases breast cancer risk. |
Mahoney, Diana |
|
May 1, 2012 |
577 |
| Skin cancer: prevention and latest treatments. |
Saini, Ritu |
Editorial |
May 1, 2012 |
626 |
| Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based Dermatologists. |
Strohal, Robert; Kerl, Helmut; Schuster, Lydia |
Report |
May 1, 2012 |
3993 |
| Trends in primary skin cancer prevention among US Hispanics: a systematic review. |
Weiss, Jonathan; Kirsner, Robert S.; Hu, Shasa |
Report |
May 1, 2012 |
4978 |
| In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells. |
Oliveira, Jaqueline Carvalho, de; Brassesco, Maria, Sol; Pezuk, Julia Alejandra; Morales, Andressa G |
Report |
May 1, 2012 |
3781 |
| Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer. |
Goldberg, Leonard H.; Landau, Jennifer M.; Moody, Megan N.; Marquez, Denise; Jih, Ming; Kimyai-Asadi |
Report |
May 1, 2012 |
2829 |
| Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. |
Martin, George M.; Stockfleth, Eggert |
|
May 1, 2012 |
6596 |
| Improved texture and appearance of humar facial skin after daily topical application of barley produced, synthetic, human-like epidermal growth factor (EGF) serum. |
Schouest, Jonathan M.; Luu, Teresa K.; Moy, Ronald L. |
Report |
May 1, 2012 |
4355 |
| Basal cell carcinoma and squamous cell carcinoma: electronic brachytherapy for the treatment of NMSC. |
|
Report |
May 1, 2012 |
305 |
| The expanding role of PCR in research and medicine. |
Bierly, Allison |
Report |
May 1, 2012 |
1623 |
| From the publisher. |
Collin, Jonathan |
|
May 1, 2012 |
1298 |
| Tocotrienols: vitamin E for cardiovascular benefits after all. |
Tan, Barrie; Trias, Anne M. |
|
May 1, 2012 |
3896 |
| Response to wall street journal editorial concerning 5-year cancer survival rates. |
Apostolides, Anthony |
Guest editorial |
May 1, 2012 |
981 |
| Reducing dangerous varicose veins with phlebotonics. |
Clachar, Sarah |
|
May 1, 2012 |
3623 |
| Fasting retards tumor growth. |
Dye, D. |
Brief article |
May 1, 2012 |
251 |
| FDA warns of counterfeit anti-cancer drug Avastin [R]. |
Finkel, J. |
Brief article |
May 1, 2012 |
209 |
| Possible prevention and treatment of prostate cancer by exercise. |
Zaslau, Stanley; Jansen, Robert; Riggs, Dale R.; Jackson, Barbara J.; Bryner, Randy W. |
Report |
May 1, 2012 |
3684 |
| Rational care or rationing care? Updates and controversies in women's prevention. |
Davisson, Laura |
Report |
May 1, 2012 |
4599 |
| Screening mammograms in Alzheimer's disease patients. |
Yousef, George M.; Sovani, Piyush; Devabhaktuni, Sirisha; Goebel, Lynne J. |
Report |
May 1, 2012 |
1991 |
| No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. |
Mahmud, Salaheddin M.; Van Caeseele, Paul; Hammond, Gregory; Kurbis, Carol; Hilderman, Tim; Elliott, |
Report |
May 1, 2012 |
8564 |
| MR of the female pelvis. |
Agrawal, Garima; Sethi, Ila; Oto, Aytekin |
Clinical report |
May 1, 2012 |
3499 |
| CARTI's new plan upsets decades-long relationship: CARTI should open new cancer center in LR by fall 2014. |
Friedman, Mark |
Company overview |
Apr 30, 2012 |
1301 |
| Therapy has fewer problems. |
|
|
Apr 30, 2012 |
312 |
| After being diagnosed wrongly I had to fight for correct cancer drug; MUM-OF-TWO IN BATTLE FOR LIFE-SAVING MEDICATION. |
|
|
Apr 30, 2012 |
864 |
| AWARENESS WEEK. |
|
|
Apr 30, 2012 |
274 |
| Altor BioScience and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor's Novel IL-15 Superagonist for Metastatic Melanoma. |
|
Clinical report |
Apr 30, 2012 |
423 |
| A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation. |
|
|
Apr 30, 2012 |
481 |
| Appeal for Wales to get cancer drug fund; CASES HIGHLIGHT PROBLEMS. |
|
|
Apr 28, 2012 |
801 |
| Great divide in healthcare is of no relevance to those fighting for their lives; Western Mail. |
|
|
Apr 28, 2012 |
471 |
| Why Not Wales? campaign fights for new drugs. |
|
|
Apr 28, 2012 |
264 |
| 'You'll do whatever you can to save your life' Woman's fight for cancer drug. |
|
|
Apr 28, 2012 |
779 |
| Iran Produces Anti-Cancer Drug from Arsenic. |
|
|
Apr 28, 2012 |
213 |
| Quality of life 'as important as quantity of life' for cancer survivors. |
|
|
Apr 28, 2012 |
531 |
| 'It is important for me to be able to make a difference' Susan Morris has recently taken over the helm of Macmillan Cancer Support in Wales, Cathy Owen met her to find out why she feels so privileged to have the job TheBIGInterview. |
|
|
Apr 27, 2012 |
1950 |
| New oncology day unit at North Tyneside Hospital. |
|
|
Apr 27, 2012 |
556 |
| 155-Pound Therapy Dog Swims His Way Into the Hearts of Cancer Patients. |
|
|
Apr 27, 2012 |
748 |
| The International Myeloma Foundation Says Pomalidomide, an Important New Drug for Patients, Has Been Submitted for FDA Approval. |
|
|
Apr 27, 2012 |
630 |
| Chavez returns home after latest cancer treatment. |
|
|
Apr 26, 2012 |
166 |
| Spire Little Aston Hospital. |
|
|
Apr 26, 2012 |
557 |
| Incyte Reports 2012 First-Quarter Financial Results; Updates Shareholders on Commercial Activity and Key Clinical Programs. |
|
|
Apr 26, 2012 |
4937 |
| Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers. |
|
|
Apr 26, 2012 |
861 |
| Research puts focus on elderly cancer patients. |
|
|
Apr 26, 2012 |
197 |
| CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer. |
|
|
Apr 26, 2012 |
1575 |
| The Coalition to Cure Prostate Cancer Breaks Ground, Announces Four Young Investigators to Advance Prostate Cancer Research. |
|
|
Apr 26, 2012 |
1247 |
| Eating pizza may help cut prostate cancer risk. |
|
|
Apr 25, 2012 |
391 |
| Pizza seasoning herb oregano may help combat prostate cancer. |
|
|
Apr 25, 2012 |
391 |
| Aspirin can cut cancer death risk by 30pc. |
|
Clinical report |
Apr 25, 2012 |
398 |
| Advaxis to Speak at 2012 World Immunotherapy Online Symposium. |
|
|
Apr 25, 2012 |
599 |
| Research and Markets: The Ovarian Cancer Therapeutics Market is Poised to Witness Three-Fold Growth until 2020 - Global Drug Forecasts and Treatment Analysis 2020. |
|
|
Apr 25, 2012 |
525 |
| Angel Flight East (AFE) and Cancer Treatment Centers of America (CTCA) Collaborate to Support Patients. |
|
|
Apr 25, 2012 |
448 |
| Cancer Research Organization Broadcasts Healthy Eating Tips with Top Chefs. |
|
|
Apr 25, 2012 |
500 |
| NEW TEST WILL CATCH BOWEL CANCER EARLY; Hopes for Irish research on killer disease. |
|
|
Apr 24, 2012 |
395 |
| Patients 'miss best cancer treatment' InBrief. |
|
|
Apr 24, 2012 |
114 |
| Secret to breast milk's anti-cancer activity revealed. |
|
|
Apr 24, 2012 |
277 |
| OMONTYS[R] (Peginesatide) Injection Now Available for Adult Chronic Kidney Disease (CKD) Patients on Dialysis in the United States. |
|
|
Apr 24, 2012 |
2063 |
| PsiOxus Therapeutics Moves into New Facilities on Milton Park to Accommodate Expansion. |
|
|
Apr 24, 2012 |
596 |
| The Untold Cost of Cancer: Changes in Appearance Due to Cancer Treatment Impact Personal Relationships According to New National Survey of Women with Cancer. |
|
|
Apr 24, 2012 |
1457 |
| The Gateway for Cancer Research Puts Patients First by Supporting Clinical Studies for Treatments Now. |
|
Clinical report |
Apr 24, 2012 |
1040 |
| Research and Markets: Recent Advances in Cancer Research and Therapy - Increased Research on one of the Major Causes of Death. |
|
|
Apr 24, 2012 |
470 |
| The Gateway For Cancer Research Helping Revive Cancer Survivors Garden. |
|
|
Apr 24, 2012 |
1562 |
| Research and Markets: Anti-cancer Drugs Market in APAC 2011-2015. |
|
|
Apr 24, 2012 |
469 |
| German Federal Regulator Confirms Additional Benefit of Anti-cancer Agent Halaven(R) for Metastatic or Locally Advanced Breast Cancer. |
|
|
Apr 24, 2012 |
1005 |
| BSD Medical Announces Study Featuring MicroThermX[R] Microwave Ablation System Presented at Society of Interventional Radiology (SIR) Conference Demonstrates Advantages of Microwave Ablation. |
|
Conference news |
Apr 23, 2012 |
570 |
| KonLin Letter Cites Clinical Trials and Future Partnerships as Rationale for its Projection of Strong Future Revenue. |
|
|
Apr 23, 2012 |
678 |
| IU Simon Cancer Center Joins WellPoint in Developing Health Care Solutions. |
|
|
Apr 23, 2012 |
1490 |
| BioTime's Subsidiary OncoCyte Corporation Provides Update on PanC-DxTM, and Related Diagnostic Products. |
|
|
Apr 23, 2012 |
1746 |
| Cancer Research Organization Broadcasts Healthy Eating Tips with Top Chefs. |
|
|
Apr 23, 2012 |
463 |
| BECAUSE WE'RE NOT WORTH IT; Scandal of skin cancer wonder drug that's too expensive for Irish people. |
|
|
Apr 21, 2012 |
448 |
| CANCER SURVIVOR CHRISTINE JOINS RUN TO SHED HER 'CHEMO POUNDS'. |
|
|
Apr 20, 2012 |
455 |
| Clues to aspirin's anti-cancer effects unlocked. |
|
|
Apr 20, 2012 |
330 |
| New gene signature helps in lung cancer''s treatment - reseachers. |
|
|
Apr 20, 2012 |
618 |
| IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability - A Promising Discovery for Breast Cancer Therapy. |
|
|
Apr 20, 2012 |
1041 |
| STUDIES FIND TEN TYPES OF BREAST CANCER; New hope for sufferers. |
|
|
Apr 19, 2012 |
333 |
